Opko Health (OPK) Short-term Investments (2011 - 2018)

Opko Health (OPK) posted Short-term Investments of $26.3 million for Q4 2018, up 68.31% quarter-over-quarter from $15.6 million in Q2 2016.

Opko Health (OPK) Short-term Investments (2011 - 2018) Analysis & Trends

Opko Health (OPK) has reported Short-term Investments for 5 consecutive years, with $26.3 million the latest figure, recorded in Q4 2018.

Short-term Investments for Q4 2018 came in at $26.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $26.3 million (changed N/A YoY), and the FY2018 annual result was $26.3 million, changed N/A from the prior year.
Short-term Investments was $26.3 million for Q4 2018 at Opko Health, up from $15.6 million in the prior quarter.
Over five years, Short-term Investments peaked at $26.3 million in Q4 2018 and troughed at $15.6 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn
10	Opko Health	1.16 Bn	819.20 Mn	45.76 Mn

Download Data